11.12.17

RESOLUTIONS AT THE EXTRAORDINARY GENERAL MEETING OF NUEVOLUTION AB (PUBL)

08.12.17

THE DANISH EASTERN HIGH COURT REVOKES THE MARITIME AND COMMERCIAL HIGH COURT’S DECISION OF 22 FEBRUARY 2016 IN FAVOUR OF NUEVOLUTION’S REQUEST

27.11.17

NUEVOLUTION TO PRESENT NEW DATA ON ITS BET BD1 PROGRAM SUPPORTING EFFECT IN PSORIASIS/ATOPIC DERMATITIS

20.11.17

NOTICE OF EXTRAORDINARY GENERAL MEETING OF NUEVOLUTION AB (PUBL)

07.11.17

NUEVOLUTION AB (PUBL) ANNOUNCES ITS REPORT FOR THE INTERIM PERIOD ENDED 30 SEPTEMBER 2017

03.11.17

NUEVOLUTION APPOINTS JOHNNY STILOU AS DIRECTOR OF INVESTOR RELATIONS AND CORPORATE COMMUNICATION

01.11.17

NUEVOLUTION AB (PUBL) ANNOUNCES TIMING FOR THE RELEASE AND WEBCAST OF THE THREE-MONTH REPORT FOR JULY-SEPTEMBER 2017

30.10.17

FREDRIK ARP IS PROPOSED AS BOARD MEMBER IN NUEVOLUTION AB (PUBL)

27.10.17

NUEVOLUTION TO PRESENT NEW DATA ON ITS BET BD1 PROGRAM SUPPORTING THE UNDERSTANDING OF THE BIOLOGICAL MODE-OF-ACTION

12.10.17

RESOLUTIONS AT THE ANNUAL GENERAL MEETING OF NUEVOLUTION AB (PUBL)

12.10.17

PRESENTATION FOR NUEVOLUTION’S ANNUAL GENERAL MEETING AND VIDEO MATERIAL BASED ON THE ANNUAL REPORT 2016/17 NOW AVAILABLE

18.09.17

NUEVOLUTION AB (PUBL) ANNUAL REPORT 2016/17 NOW AVAILABLE

18.09.17

NUEVOLUTION AB (PUBL) INTENDS TO MOVE THE LISTING OF ITS SHARES TO NASDAQ STOCKHOLM’S MAIN MARKET DURING THE FISCAL YEAR 2017/18

12.09.17

NOTICE OF ANNUAL GENERAL MEETING OF NUEVOLUTION AB (PUBL)

11.09.17

NUEVOLUTION TO PRESENT AT THREE INVESTOR CONFERENCES IN SEPTEMBER 2017

06.09.17

NUEVOLUTION AB (PUBL) ANNOUNCES ITS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2016/17

30.08.17

CORRECTION OF: NUEVOLUTION AB (PUBL) ANNOUNCES TIMING FOR THE FOURTH QUARTER RELEASE AND WEBCAST

30.08.17

NUEVOLUTION AB (PUBL) ANNOUNCES TIMING FOR THE FOURTH QUARTER RELEASE AND WEBCAST

19.06.17

NUEVOLUTION PRESENTS ADDITIONAL POSITIVE ANIMAL RESULTS IN LUPUS FROM ITS BET SELECTIVE PROGRAM

12.06.17

NUEVOLUTION TO PRESENT AT ANGLO-NORDIC MEDICINAL CHEMISTRY SYMPOSIUM

17.05.17

NUEVOLUTION AB (PUBL) ANNOUNCES ITS RESULTS FOR THE THIRD QUARTER 2016/17

10.05.17

NUEVOLUTION AB (PUBL) ANNOUNCES TIMING FOR THE THIRD QUARTER RELEASE AND WEBCAST

20.03.17

BIOEUROPE SPRING 2017 PRESENTATION OF PROGRESS IN THREE PIPELINE PROGRAMS

06.03.17

NUEVOLUTION ANNOUNCES FURTHER TECHNOLOGY ACCESS FEE PAYMENT FROM ITS DRUG DISCOVERY COLLABORATION WITH JANSSEN

14.02.17

NUEVOLUTION TECHNOLOGY PROGRESS: NUEVOLUTION SCALES ITS COMPOUND COLLECTION TO 40 TRILLION USING ITS CHEMETICS™ DRUG DISCOVERY PLATFORM

08.02.17

NUEVOLUTION AB (PUBL) ANNOUNCES ITS RESULTS FOR THE SECOND QUARTER 2016/17

02.02.17

NUEVOLUTION AB (PUBL) ANNOUNCES TIMING FOR THE SECOND QUARTER RELEASE AND WEBCAST

23.01.17

NUEVOLUTION ANNOUNCES THE PUBLICATION OF A SCIENTIFIC ARTICLE IN COLLABORATION WITH NOBEL LAUREATE DR. ROBERT J. LEFKOWITZ